Navigating Forward in the New Normal
During uncertain times, it crucial to maintain efficiency, flexibility, and continuity throughout the value chain. COVID-19 has changed the way various industries conduct their usual business, particularly the life sciences industry.
In this whitepaper, Pharmaceutical Technology sat down with DocuSign to explore how the company leverages its technology to help keep value chain processes moving forward. You’ll learn:
- Important changes in technology that are paramount for life science companies to address
- How suppliers are ensuring that their software is secure and complies with General Data Protection Regulation (GDPR)
- The key value that DocuSign has brought to life sciences companies